The leukocyte immunoglobulin-like receptor family member LILRB5 binds to HLA-class I heavy chains

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Zhang, Zhiyong ^a,c   Hatano, Hiroko ^a   Shaw, Jacqueline ^a   Nordkamp, Marloes Olde ^b   Jiang, Guosheng ^c   Li, Demin ^b   Kollnberger, Simon ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR A1; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR A4; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR A5; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR A6; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B2; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR B5; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; HLA B7 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB5 PROTEIN, HUMAN; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BASOPHIL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HEAVY CHAIN; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INNATE IMMUNITY; LIGAND BINDING; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; METABOLISM;

RATTUS;

ANIMALS; ANTIGENS, CD; CELL LINE; HLA-B27 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; PROTEIN BINDING; RATS; RECEPTORS, IMMUNOLOGIC;

EID: 84939222061     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129063     Document Type: Article

References (30)

1. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue antigens. 2004; 64(3):215-25. Epub 2004/08/12. doi: 10.1111/j.0001-2815.2004.00290.x PMID: 15304001.
2. Zheng J, Umikawa M, Cui C, Li J, Chen X, Zhang C, et al. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature. 2012; 485(7400):656-60. Epub 2012/06/05. doi: 10.1038/nature11095 PMID: 22660330; PubMed Central PMCID: PMC3367397.
3. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 1997; 159(11):5192-6. PMID: 9548455.
4. Tedla N, Lee CW, Borges L, Geczy CL, Arm JP. Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells. J Leukoc Biol. 2008; 83(2):334-43. PMID: 17998301.
5. Jones DC, Roghanian A, Brown DP, Chang C, Allen RL, Trowsdale J, et al. Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. European journal of immunology. 2009; 39(11):3195-206. Epub 2009/08/07. doi: 10.1002/eji.200839080 PMID: 19658091.
6. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol. 2001; 167(10):5543-7. Epub 2001/11/08. PMID: 11698424.
7. Shiroishi M, Kuroki K, Rasubala L, Tsumoto K, Kumagai I, Kurimoto E, et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(44):16412-7. PMID: 17056715.
8. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. Journal of immunology. 2011; 186 (5):2990-7. Epub 2011/01/29. doi: 10.4049/jimmunol.1003078 PMID: 21270408.
9. Allen RL, Raine T, Haude A, Trowsdale J, Wilson MJ. Leukocyte receptor complex-encoded immuno-modulatory receptors show differing specificity for alternative HLA-B27 structures. J Immunol. 2001; 167(10):5543-7. PMID: 11698424.
10. Giles J, Shaw J, Piper C, Wong-Baeza I, McHugh K, Ridley A, et al. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I. Journal of immunology. 2012; 188(12):6184-93. Epub 2012/05/18. doi: 10.4049/jimmunol.1102711 PMID: 22593621.
11. Masuda A, Nakamura A, Maeda T, Sakamoto Y, Takai T. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation. The Journal of experimental medicine. 2007; 204 (4):907-20. PMID: 17420263.
12. Deng M, Lu Z, Zheng J, Wan X, Chen X, Hirayasu K, et al. A motif in LILRB2 critical for Angptl2 binding and activation. Blood. 2014; 124(6):924-35. Epub 2014/06/06. doi: 10.1182/blood-2014-01-549162 PMID: 24899623; PubMed Central PMCID: PMC4126332.
13. Brown M, Pile K, Kennedy L, Calin A, Darke C, Bell J, et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Annals of the rheumatic diseases. 1996; 55 (4):268-70. PMID: 8733445.
14. Allen RL, O'Callaghan CA, McMichael AJ, Bowness P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J Immunol. 1999; 162(9):5045-8. PMID: 10227970.
15. Payeli SK, Kollnberger S, Marroquin Belaunzaran O, Thiel M, McHugh K, Giles J, et al. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis and rheumatism. 2012; 64 (10):3139-49. Epub 2012/05/12. doi: 10.1002/art.34538 PMID: 22576154.
16. Kollnberger S, Bowness P. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Advances in experimental medicine and biology. 2009; 649:277-85. Epub 2009/09/08. PMID: 19731637.
17. Burlingham WJ, Ceman SS, DeMars R. Secretion and cell surface expression of IgG1 are impaired in human B lymphoblasts that lack HLA-A, -B, and -C antigens. Proc Natl Acad Sci U S A. 1989; 86 (20):8005-9. PMID: 2682635.
18. Bird LA, Peh CA, Kollnberger S, Elliott T, McMichael AJ, Bowness P. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. European journal of immunology. 2003; 33(3):748-59. Epub 2003/03/05. doi: 10.1002/eji.200323678 PMID: 12616495.
19. Wong-Baeza I, Ridley A, Shaw J, Hatano H, Rysnik O, McHugh K, et al. KIR3DL2 Binds to HLA-B27 Dimers and Free H Chains More Strongly than Other HLA Class I and Promotes the Expansion of T Cells in Ankylosing Spondylitis. Journal of immunology. 2013; 190(7):3216-24. Epub 2013/02/27. doi: 10.4049/jimmunol.1202926 PMID: 23440420.
20. Cauli A, Shaw J, Giles J, Hatano H, Rysnik O, Payeli S, et al. The arthritis-associated HLA-B∗27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B∗27:09. Rheumatology. 2013. Epub 2013/06/28. doi: 10.1093/rheumatology/ket219 PMID: 23804219.
21. Kollnberger S, Bird L, Sun MY, Retiere C, Braud VM, McMichael A, et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis and rheumatism. 2002; 46(11):2972-82. Epub 2002/11/13. doi: 10.1002/art.10605 PMID: 12428240.
22. Kollnberger S, Chan A, Sun MY, Chen LY, Wright C, di Gleria K, et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. European journal of immunology. 2007; 37(5):1313-22. PMID: 17407096.
23. Ryu M, Chen Y, Qi J, Liu J, Fan Z, Nam G, et al. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence. PLoS One. 2011; 6(4):e19245. Epub 2011/05/12. doi: 10.1371/journal.pone.0019245 PMID: 21559424; PubMed Central PMCID: PMC3084784.
24. Chen Y, Gao F, Chu F, Peng H, Zong L, Liu Y, et al. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its nonbinding to MHC complexes. Journal of molecular biology. 2009; 386(3):841-53. Epub 2009/02/21. PMID: 19230061.
25. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol. 2003; 4(9):913-9. Epub 2003/08/05. doi: 10. 1038/ni961 PMID: 12897781.
26. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 1998; 160(7):3096-100. Epub 1998/04/08. PMID: 9531263.
27. Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR, Borges L. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol. 1998; 28 (11):3423-34. Epub 1998/12/08. doi: 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2 PMID: 9842885.
28. Jones DC, Kosmoliaptsis V, Apps R, Lapaque N, Smith I, Kono A, et al. HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. J Immunol. 2011; 186(5):2990-7. Epub 2011/01/29. doi: 10.4049/jimmunol.1003078 PMID: 21270408.
29. Cheng H, Mohammed F, Nam G, Chen Y, Qi J, Garner LI, et al. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance. The Journal of biological chemistry. 2011; 286(20):18013-25. Epub 2011/04/02. doi: 10.1074/jbc.M111. 221028 PMID: 21454581; PubMed Central PMCID: PMC3093875.
30. Cheng H, Mohammed F, Nam G, Chen Y, Qi J, Garner LI, et al. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance. J Biol Chem. 2011; 286(20):18013-25. Epub 2011/04/02. doi: 10.1074/jbc.M111.221028 PMID: 21454581; PubMed Central PMCID: PMC3093875.